Cancer Research 09 AM Call for Abstracts  SU2C
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Staib, F.
Right arrow Articles by Harris, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Staib, F.
Right arrow Articles by Harris, C. C.
[Cancer Research 65, 10255-10264, November 15, 2005]
© 2005 American Association for Cancer Research


Molecular Biology, Pathobiology and Genetics

The p53 Tumor Suppressor Network Is a Key Responder to Microenvironmental Components of Chronic Inflammatory Stress

Frank Staib1, Ana I. Robles1, Lyuba Varticovski1, Xin W. Wang1, Barry R. Zeeberg2, Michail Sirotin3, Victor B. Zhurkin3, Lorne J. Hofseth4, S. Perwez Hussain1, John N. Weinstein2, Peter R. Galle5 and Curtis C. Harris1

1 Laboratories of Human Carcinogenesis, 2 Molecular Pharmacology, and 3 Experimental and Computational Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; 4 Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina; and 5 First Department of Internal Medicine, Johannes Gutenberg University of Mainz, Mainz, Germany

Requests for reprints: Curtis C. Harris, Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, 37 Convent Drive, Room 3068, MSC 4255, Bethesda, MD 20892-4255. Phone: 301-496-2048; Fax: 301-496-0497; E-mail: curtis_harris{at}nih.gov.

Activation of the p53 network plays a central role in the inflammatory stress response associated with ulcerative colitis and may modulate cancer risk in patients afflicted with this chronic disease. Here, we describe the gene expression profiles associated with four microenvironmental components of the inflammatory response (NO{bullet}, H2O2, DNA replication arrest, and hypoxia) that result in p53 stabilization and activation. Isogenic HCT116 and HCT116 TP53–/– colon cancer cells were exposed to the NO{bullet} donor Sper/NO, H2O2, hypoxia, or hydroxyurea, and their mRNA was analyzed using oligonucleotide microarrays. Overall, 1,396 genes changed in a p53-dependent manner (P < 0.001), with the majority representing a "unique" profile for each condition. Only 14 genes were common to all four conditions. Included were eight known p53 target genes. Hierarchical sample clustering distinguished early (1 and 4 hours) from late responses (8, 12, and 24 hours), and each treatment was differentiated from the others. Overall, NO{bullet} and hypoxia stimulated similar transcriptional responses. Gene ontology analysis revealed cell cycle as a key feature of stress responses and confirmed the similarity between NO{bullet} and hypoxia. Cell cycle profiles analyzed by flow cytometry showed that NO{bullet} and hypoxia induced quiescent S-phase and G2-M arrest. Using a novel bioinformatic algorithm, we identified several putative p53-responsive elements among the genes induced in a p53-dependent manner, including four [KIAA0247, FLJ12484, p53CSV (HSPC132), and CNK (PLK3)] common to all exposures. In summary, the inflammatory stress response is a complex, integrated biological network in which p53 is a key molecular node regulating gene expression.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
X. Deng, M. J. Liguori, E. M. Sparkenbaugh, J. F. Waring, E. A. G. Blomme, P. E. Ganey, and R. A. Roth
Gene Expression Profiles in Livers from Diclofenac-Treated Rats Reveal Intestinal Bacteria-Dependent and -Independent Pathways Associated with Liver Injury
J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 634 - 644.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Kumamoto, E. A. Spillare, K. Fujita, I. Horikawa, T. Yamashita, E. Appella, M. Nagashima, S. Takenoshita, J. Yokota, and C. C. Harris
Nutlin-3a Activates p53 to Both Down-regulate Inhibitor of Growth 2 and Up-regulate mir-34a, mir-34b, and mir-34c Expression, and Induce Senescence
Cancer Res., May 1, 2008; 68(9): 3193 - 3203.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Bhattacharyya, A. Borthakur, P. K. Dudeja, and J. K. Tobacman
Carrageenan Induces Cell Cycle Arrest in Human Intestinal Epithelial Cells in Vitro
J. Nutr., March 1, 2008; 138(3): 469 - 475.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M.G. Luciani, C. Campregher, and C. Gasche
Aspirin blocks proliferation in colon cells by inducing a G1 arrest and apoptosis through activation of the checkpoint kinase ATM
Carcinogenesis, October 1, 2007; 28(10): 2207 - 2217.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Tang, M. Molina, and S. Amar
p53 Short Peptide (p53pep164) Regulates Lipopolysaccharide-Induced Tumor Necrosis Factor-{alpha} Factor/Cytokine Expression
Cancer Res., February 1, 2007; 67(3): 1308 - 1316.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.